<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Adiponectin is a fat-derived plasma protein that has beneficial actions on <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A low level of plasma adiponectin is associated with increased mortality after <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>; however, the causal role of adiponectin in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: To explore the role of adiponectin in the development of <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral injury, we subjected adiponectin-deficient (APN-KO) and <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice to 1 hour of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 23 hours of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>APN-KO mice exhibited <z:mp ids='MP_0005238'>enlarged brain</z:mp> infarction and increased neurological deficits after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion compared with WT mice </plain></SENT>
<SENT sid="4" pm="."><plain>Conversely, adenovirus-mediated supplementation of adiponectin significantly reduced cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size in WT and APN-KO mice </plain></SENT>
<SENT sid="5" pm="."><plain>APN-KO mice showed decreased cerebral blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> by laser speckle flowmetry methods </plain></SENT>
<SENT sid="6" pm="."><plain>Adiponectin colocalized within the cerebral vascular endothelium under transient ischemic conditions by immunohistochemical analysis </plain></SENT>
<SENT sid="7" pm="."><plain>Phosphorylation of endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase in ischemic brain tissues and the production of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> metabolites in plasma were attenuated in APN-KO mice compared with WT mice </plain></SENT>
<SENT sid="8" pm="."><plain>Adenovirus-mediated administration of adiponectin stimulated endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase phosphorylation and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> metabolites during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in both WT and APN-KO mice </plain></SENT>
<SENT sid="9" pm="."><plain>Neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase expression during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> did not differ between WT and APN-KO mice </plain></SENT>
<SENT sid="10" pm="."><plain>Adenovirus-mediated delivery of adiponectin did not affect <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> in mice deficient in endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These data provide causal evidence that adiponectin exerts a cerebroprotective action through an endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase-dependent mechanism </plain></SENT>
<SENT sid="12" pm="."><plain>Adiponectin could represent a molecular target for the prevention of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>